首页> 外文期刊>Cellular Physiology and Biochemistry >MiR-144 Increases Intestinal Permeability in IBS-D Rats by Targeting OCLN and ZO1
【24h】

MiR-144 Increases Intestinal Permeability in IBS-D Rats by Targeting OCLN and ZO1

机译:MiR-144通过靶向OCLN和ZO1增加IBS-D大鼠的肠通透性

获取原文
           

摘要

biBackground/Aims/i/b Irritable bowel syndrome with diarrhoea (IBS-D) is a chronic, functional bowel disorder characterized by abdominal pain or diarrhoea and altered bowel habits, which correlate with intestinal hyperpermeability. MicroRNAs (miRNAs) are involved in regulating intestinal permeability in IBS-D. However, the role of miRNAs in regulating intestinal permeability and protecting the epithelial barrier remains unclear. Our goals were to (i) identify differential expression of miRNAs and their targets in the distal colon of IBS-D rats; (ii) verify iin vitro/i whether occludin (OCLN) and zonula occludens 1 (ZO1/TJP1) were direct targets of miR-144 and were down-regulated in IBS-D rats; and (iii) determine whether down-regulation of miR-144 iin vitro/i could reverse the pathological hallmarks of intestinal hyperpermeability via targeting OCLN and ZO1. biMethods/i/b The IBS-D rat model was established using 4% acetic acid and evaluated by haematoxylin-eosin (HE) staining. The distal colon was obtained in order to perform miRNA microarray analysis and to isolate and culture colonic epithelial cells. When differential expression of miRNA was found, the results were verified by qRT-PCR, and the target genes were further explored by bioinformatics analysis. Correlation analyses were carried out to compare the expression of miRNA and target genes. Then, mutants, miRNA mimics and inhibitors of the target genes were constructed and transfected to colonic epithelial cells. qRT-PCR, western blotting, enzyme-linked immunosorbent assays (ELISAs) and dual-luciferase assays were used to investigate the expression of miR-144 and OCLN, ZO1 in IBS-D rats. biResults/i/b There were 8 up-regulated and 18 down-regulated miRNAs identified in the IBS-D rat model. Of these, miR-144 was markedly up-regulated and resulted in the down-regulation of OCLN and ZO1 expression. Overexpression of miR-144 by transfection of miR-144 precursor markedly inhibited the expression of OCLN and ZO1. Further studies confirmed that OCLN and ZO1 were direct targets of miR-144. Additionally, intestinal hyperpermeability was enhanced by miR-144 up-regulation and attenuated by miR-144 down-regulation in IBS-D rat colonic epithelial cells. Moreover, rescue experiments showed that overexpression of OCLN and ZO1 significantly eliminated the inhibitory effect of miR-144, which showed a stronger effect on the attenuation of intestinal hyperpermeability. biConclusion/i/b Up-regulation of miR-144 could promote intestinal hyperpermeability and impair the protective effect of the epithelial barrier by directly targeting OCLN and ZO1. miR-144 is likely a key regulator of intestinal hyperpermeability and could be a potential therapeutic target for IBS-D.
机译:背景/目标 腹泻型肠易激综合症(IBS-D)是一种慢性功能性肠病,其特征在于腹痛或腹泻和排便习惯改变,与肠道通透性高有关。 MicroRNA(miRNA)参与调节IBS-D的肠道通透性。然而,miRNA在调节肠通透性和保护上皮屏障中的作用尚不清楚。我们的目标是(i)在IBS-D大鼠的远端结肠中鉴定miRNA及其靶标的差异表达; (ii)体外验证闭合蛋白(OCLN)和小带闭合蛋白1(ZO1 / TJP1)是否是miR-144的直接靶标并在IBS-D大鼠中被下调; (iii)通过靶向OCLN和ZO1确定miR-144体外下调是否可以逆转肠道高通透性的病理学特征。 方法 使用4%的乙酸建立IBS-D大鼠模型,并用苏木精-伊红(HE)染色进行评估。为了进行miRNA微阵列分析以及分离和培养结肠上皮细胞,获得了远端结肠。当发现miRNA的差异表达时,通过qRT-PCR验证了结果,并通过生物信息学分析进一步探索了靶基因。进行相关分析以比较miRNA和靶基因的表达。然后,构建靶基因的突变体,miRNA模拟物和抑制剂,并将其转染到结肠上皮细胞中。使用qRT-PCR,western印迹,酶联免疫吸附测定(ELISA)和双重荧光素酶测定来研究miR-144和OCLN,ZO1在IBS-D大鼠中的表达。 结果 在IBS-D大鼠模型中鉴定出8个上调的miRNA和18个下调的miRNA。其中,miR-144显着上调并导致OCLN和ZO1表达下调。通过转染miR-144前体来过度表达miR-144显着抑制OCLN和ZO1的表达。进一步的研究证实OCLN和ZO1是miR-144的直接靶标。此外,在IBS-D大鼠结肠上皮细胞中,miR-144的上调增强了肠的通透性,而miR-144的下调则减弱了肠的通透性。此外,急救实验表明,OCLN和ZO1的过表达显着消除了miR-144的抑制作用,对肠道高通透性的减弱表现出更强的作用。 结论 通过直接靶向OCLN和ZO1,miR-144的上调可促进肠道通透性过高,并损害上皮屏障的保护作用。 miR-144可能是肠道通透性的关键调节剂,并且可能是IBS-D的潜在治疗靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号